Skip to content

800.850.4306

  • About Us
    • Who We Are
    • Leadership
    • Accreditations
    • Careers
  • Insights
    • News
    • Our Stories
    • Events
  • Contact Us
  • About Us
    • Who We Are
    • Leadership
    • Accreditations
    • Careers
  • Insights
    • News
    • Our Stories
    • Events
  • Contact Us
  • Patients
    • Oncology
    • Rare and Orphan Care
    • Cell and Gene Therapy
    • Financial Assistance
    • Frequently Asked Questions
  • Providers
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
    • Cell and Gene Therapy
  • Biopharma
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
    • Cell and Gene Therapy
  • Payers
  • How to Prescribe
    • Specialty Drugs List
  • Patients
    • Oncology
    • Rare and Orphan Care
    • Cell and Gene Therapy
    • Financial Assistance
    • Frequently Asked Questions
  • Providers
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
    • Cell and Gene Therapy
  • Biopharma
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
    • Cell and Gene Therapy
  • Payers
  • How to Prescribe
    • Specialty Drugs List

Author: Sarah

FRUZAQLA (fruquintinib), FDA Approved for the Treatment of Metastatic Colorectal Cancer, Available at Biologics by McKesson

Image with text: "Biologics is now offering FRUZAQLATM (fruquintinib)"

CARY, N.C., Nov. 15, 2023—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by […]

OJJAARA (momelotinib), FDA Approved for the Treatment of Myelofibrosis in Adults with Anemia, Available at Biologics by McKesson

Biologics is now offering OJJAARA (momelotinib)

CARY, N.C., Sept. 20, 2023—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by […]

Video Transcript: Risk-Based Care: Personalized care for better patient outcomes

Risk-Based Care: Personalized care for better patient outcomes Daniel Weaver, BSN, RN, Director, Clinical Innovation and Strategy, Biologics by McKesson: When […]

Video Transcript: Risk-Based Care: Personalized care for better outcomes | Dan & Porscha

Risk-Based Care: Personalized care for better outcomes | Dan & Porscha Daniel Weaver, BSN, RN, Director, Clinical Innovation and Strategy, […]

VANFLYTA (quizartinib), FDA Approved in the U.S. for Newly Diagnosed FLT3-ITD Positive Acute Myeloid Leukemia, Available at Biologics by McKesson

Biologics by McKesson is a specialty pharmacy provider for VANFLYTATM (quizartinib)

CARY, N.C., Aug. 4, 2023 — Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was […]

Improving Oncology Patient Outcomes: The Future of Risk-Based Care

Ela Lourido, Biologics VP Biopharma

Research shows that Biologics by McKesson’s pioneering risk-based care program maximizes patients’ time on therapy, leading to better oncology patient outcomes.

Video Transcript: Patient Spotlight – Dan W. and Nurse Porscha Scales

Biologics by McKesson Patient Voice Spotlight – Dan W. Yvonne Sims, Senior Manager, Marketing, Biologics by McKesson: So take us to […]

Biologics by McKesson Named the Exclusive Pharmacy for FDA- Approved SKYCLARYS (omaveloxolone) for the Treatment of Friedreich’s Ataxia

Biologics is the exclusive pharmacy for SKYCLARYS (omaveloxolone) 50mg capsules

CARY, N.C., April 5, 2023 — Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was […]

JAYPIRCA (pirtobrutinib), FDA Approved for Treatment of Relapsed or Refractory Mantle Cell Lymphoma, Available at Biologics by McKesson

Biologics is a specialty pharmacy provider for JAYPIRCA (pirtobrutinib)

CARY, N.C., Feb. 14, 2023—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]

ORSERDU (elacestrant), FDA Approved for ER+/HER2- Advanced or Metastatic Breast Cancer, Available at Biologics by McKesson

Biologics is a limited distribution network specialty pharmacy provider for ORSERDU™ (elacestrant).

CARY, N.C., Feb. 10, 2023—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected […]

Next →

11800 Weston Parkway
Cary, NC 27513
T. 800.850.4306

Legal

  • Privacy Notice
  • Terms of Use
  • Nondiscrimination Notice
  • Change Healthcare HIPAA Substitute Notice
  • Privacy Notice
  • Terms of Use
  • Nondiscrimination Notice
  • Change Healthcare HIPAA Substitute Notice

For Patients

  • Privacy Practices (PDF)
  • Patient’s Rights (PDF)
  • Privacy Practices (PDF)
  • Patient’s Rights (PDF)

Learn more about McKesson

  • Home
  • Patients
  • Providers
  • Payers
  • Biopharma
  • News
  • Careers
  • About Us
  • Contact
  • Resources
  • How to Prescribe
  • Home
  • Patients
  • Providers
  • Payers
  • Biopharma
  • News
  • Careers
  • About Us
  • Contact
  • Resources
  • How to Prescribe

© 2025 McKesson Corporation. All Rights Reserved.